Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide.
Targeted therapies hold promise for HCC treatment, and understanding the molecular mechanisms of action is crucial for developing novel therapeutic strategies.
Polyphyllin I, a natural compound with known antitumor activity, represents a potential therapeutic candidate.
